Neuralink- An Elon Musk Start-up Achieve symbiosis with Artificial Intelligence

Kulshreshth, Abhinav; Anand, Abhineet; Lakanpal, Anupam

doi:10.1109/icccis48478.2019.8974470

Cited by 12 publications

(15 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Neuralink device contains an array of 96 small, flexible electrode threads with 32 independent arrays per thread totaling 3,072 electrodes per array [3,18]. Previous research with DBS has allowed of control of computer cursors, robotic limbs, and speech synthesizers using no more than 256 electrodes [4].…”

Section: Engineering Innovation and Early Testingmentioning

confidence: 99%

“…The use of individually implanted threads with many electrodes allows for an exponential increase of channel count over older brain-machine technology [2,4]. This large number of electrodes allows for an increase in accuracy, classification, and interpretation of brain electrical activity and an increase in the transfer of a high volume of data which can be read, amplified, and sent to a machine for interpretation, or can be used to send signals to the brain to help in the treatment of other brain disorders [3,4,18]. Musk and his team have experimented with different metal and polymer types and believe a biocompatible polyimide over a gold, thin film trace is the best option for the threads.…”

Section: Engineering Innovation and Early Testingmentioning

confidence: 99%

“…Neuralink is a startup company by Tesla founder, Elon Musk, registered in 2016. Little information was known about the company until a white paper report was released on July 16, 2019 which detailed the purpose of the company and its various projects [1][2][3]. Neuralink as a company aims to "understand and treat brainly disorders," "preserve and enhance our brain," and "create a well-aligned future" [3].…”

Section: Introductionmentioning

confidence: 99%

“…Future goals of the company aim to help individuals with various forms of physical disability, enable humans to connect their brains to machines, and achieve symbiosis with artificial intelligence (AI) [2][3][4]. Some potential benefits within the medical community include helping individuals with controlling the movement of an exoskeleton or other robotics with their mind, allowing communication for patients with medical disabilities such as locked-in syndrome, restoring neuronal connections lost in degenerative disorders such as Alzheimer's disease, monitoring and training of human's psychophysiological states and cognitive abilities, and aiding in seizure prevention and treatment of drug-resistant epilepsy [1,2,5].…”

Section: Introductionmentioning

confidence: 99%

“…Some potential benefits within the medical community include helping individuals with controlling the movement of an exoskeleton or other robotics with their mind, allowing communication for patients with medical disabilities such as locked-in syndrome, restoring neuronal connections lost in degenerative disorders such as Alzheimer's disease, monitoring and training of human's psychophysiological states and cognitive abilities, and aiding in seizure prevention and treatment of drug-resistant epilepsy [1,2,5]. Outside of the medical community, Neuralink hopes to fill the void for when AI can simulate all our brainly functions and allow the human brain to compete with AI [3].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

An Examination of Prospective Uses and Future Directions of Neuralink: The Brain-Machine Interface

Reardon

Ayres

Cline

et al. 2021

Cureus

View full text Add to dashboard Cite

The human brain is one of the most mystifying biological structures in nature. Overwhelming research, technology, and innovations in neuroscience have augmented clinical assessments, diagnosis, and treatment capabilities. Nonetheless, there is still much to be discovered about nervous system disorders and defects. Neuralink, a neurotechnology company, is advancing the field of neuroscience and neuroengineering. The company's initial aim is to develop an implantable brain-machine interface device that will enhance the lives of people with severe brain and spinal cord injuries. Here, we provide insight into Neuralink's design, early testing, and future applications in neurosurgery. While early testing with small and large animals show promising results, no clinical trials have been conducted to date. Additionally, a term search for "Neuralink" was performed in PubMed. The literature search yielded only 28 references, of which most indirectly mentioned the device but not in direct testing. In order to conclude the safety and viability of the Neuralink device, further research studies are needed to move forward beyond speculation.

show abstract

Section: Engineering Innovation and Early Testingmentioning

confidence: 99%